2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン

危険有害性情報のコード(GHS)

• 絵表示(GHS)

  

• 注意喚起語

  Danger

• 危険有害性情報

  H301：飲み込むと有毒

2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン 価格

2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン 化学特性,用途語,生産方法

• 説明

  BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains (K_ds = 14.1 and 239 nM; IC₅₀s = 75 nM and 3.4 μM, respectively) that demonstrates cellular activity by semi-quantitative FRAP assay with ~90% inhibition of BRD9 and BRD7 at 0.1 μM and 1 μM, respectively. It does not bind to other bromodomain-containing BET family members (IC₅₀s >100 μM as assessed by AlphaScreen), kinases, or G protein-coupled receptors and shows off-target selectivity only to the CECR2 bromodomain in in vitro ITC assays (K_d = 258 nM), but not in cell-based assays at concentrations up to 1 μM. BI-9564 has been shown to inhibit the growth of EOL-1 AML cells both in vitro (EC₅₀ = 800 nM) and in a disseminated mouse model of AML (180 mg/kg/day). See the Structural Genomics Consortium (SGC) website for more information.

2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン 生産企業

Global(64)Suppliers

2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン スペクトルデータ(¹HNMR)

1883429-22-8, 2-メチル-4-[2,5-ジメトキシ-4-[(ジメチルアミノ)メチル]フェニル]-2,7-ナフチリジン-1(2H)-オン キーワード